Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir-Reference-Cited by-同舟云学术

Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir

Published:2009-03 Issue:3 Volume:50 Page:290-293
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Haas David W,Koletar Susan L,Laughlin Laura,Kendall Michelle A,Suckow Carol,Gerber John G,Zolopa Andrew R,Bertz Richard,Child Michael J,Hosey Lara,Alston-Smith Beverly,Acosta Edward P

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference6 articles.

1. Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.;Johnson;AIDS,2005

2. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.;Acosta;Antimicrob Agents Chemother,2007

3. Effect of rifampin on steady-state pharmacokinetics of atazanavir with ritonavir in healthy volunteers.;Burger;Antimicrob Agents Chemother,2006

4. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets.;Nijland;AIDS,2008

5. Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers.;la Porte;Antimicrob Agents Chemother,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis, prevention and risk-management of drug-induced liver injury due to medications used to treat mycobacterium tuberculosis;Expert Opinion on Drug Safety;2024-09-04

2. Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis;Viruses;2024-03-23

3. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

4. Pharmacokinetics and Safety of Twice-daily Ritonavir-boosted Atazanavir With Rifampicin;Clinical Infectious Diseases;2023-11-20

5. Activation of PXR causes drug interactions with Paxlovid in transgenic mice;Acta Pharmaceutica Sinica B;2023-11